Lemzoparlimab (Anti-CD47)
Lemzoparlimab (anti-CD47) is a human monoclonal antibody targeting the human cell surface antigen CD47 with potential phagocytosis-inducing and antineoplastic activities. MW: 145.58 KD.
| Supplier | Selleck Chemicals |
|---|---|
| Product # | A2921 |
| Sku # | A2921-1mg*5 |
| Pricing | 1mg*5, $970.00 |